• Mashup Score: 0
    Using MRD to guide treatment decisions in the clinic - 3 year(s) ago

    Jesus San Miguel, MD, Universidad de Navarra, Navarra, Spain, discusses the use of measurable residual disease (MRD) to guide treatment…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      @VJHemOnc are highlighting the latest in #mmMRD during #Myeloma Action Month. Today’s update is from Jesus San Miguel (@unav), on using #MRD to guide treatment decisions in the clinic. Check it out here! 👉https://t.co/sNp2r4zXhr👈 #COMy20 #IAMRESILIENT2021 #MMSM #HemOnc https://t.co/9X1zFOGmJr

  • Mashup Score: 1
    Why do we need to harmonize the use of MRD in MM? - 3 year(s) ago

    During the 6th World Congress on Controversies in Multiple Myeloma (COMy) the Multiple Myeloma Hub spoke to Bruno Paiva, University of Navarra, Pamplona, ES, about the use of measurable residual disease (MRD) in MM. We asked, Why do we need to harmonize the use of MRD in MM?

    Source: multiplemyelomahub.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MM_Hub
      MM_Hub

      📽️ Watch Bruno Paiva speaking with the @MM_Hub during #COMy20 in this video. We asked, Why do we need to harmonize the use of MRD in MM? https://t.co/zydm2l1wVh #mmsm #myeloma https://t.co/ohdDA79apW

  • Mashup Score: 3
    MRD in myeloma - 3 year(s) ago

    Keith Stewart, MB, ChB, Mayo Clinic, Rochester, MN, talks on the assessment of measurable residual disease (MRD) in multiple myeloma….

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      .@akeithstewart at @MayoClinic went on to discuss the evidence for prolonging maintenance therapy after #mmMRD negativity. #MultipleMyeloma #ASH20 @ASH_hematology #HemOnc Watch our recent interview with Keith at #CoMy20 on #mmMRD https://t.co/Z1iSOYe2X5

  • Mashup Score: 4
    New modalities of immunotherapy for myeloma - 3 year(s) ago

    Sagar Lonial, MD, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the new modalities of immunotherapy for myeloma. For…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: New modalities of immunotherapy for #Myeloma w/ @SagarLonialMD of @EmoryMedicine: https://t.co/dXeVvAZulp #HemOnc #MMsm @COMyCongress #COMy20 #OncoAlert #Myeloma #MultipleMyeloma #ImmunoOnc

  • Mashup Score: 0
    Latest advances in AL amyloidosis treatment - 3 year(s) ago

    During the 6th World Congress on Controversies in Multiple Myeloma (COMy) the Multiple Myeloma Hub spoke to Giampaolo Merlini, University of Pavia, Pavia, IT, about the latest advances in AL amyloidosis treatment.

    Source: multiplemyelomahub.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MM_Hub
      MM_Hub

      CONGRESS | #COMy20 | Watch the @MM_Hub interview with Giampaolo Merlini, @unipv, about the latest advances in AL #amyloidosis treatment. In the following weeks, we will be covering a series of articles about AL amyloidosis. Stay up-to-date with us! https://t.co/91XdhjPTST #mmsm https://t.co/ddZrJDtDAj

  • Mashup Score: 0
    The assets of MRD in myeloma - 3 year(s) ago

    Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, discusses three important assets of measurable residual disease (MRD) in multiple myeloma….

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: The assets of MRD in #Myeloma w/ Bruno Paiva of @unav: https://t.co/ArUeXHoKch #HemOnc #MMsm @COMyCongress #COMy20 #OncoAlert #Myeloma #MultipleMyeloma

Load More